162 related articles for article (PubMed ID: 12438962)
1. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients.
Ferrari P; Schroeder V; Anderson S; Kocovic L; Vogt B; Schiesser D; Marti HP; Ganz R; Frey FJ; Kohler HP
Transplantation; 2002 Oct; 74(8):1147-52. PubMed ID: 12438962
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients.
Chow KM; Szeto CC; Szeto CY; Poon P; Lai FM; Li PK
Transplantation; 2002 Dec; 74(12):1791-4. PubMed ID: 12499900
[TBL] [Abstract][Full Text] [Related]
3. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
4. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
[TBL] [Abstract][Full Text] [Related]
5. Relationship of Plasminogen Activator Inhibitor 1 4G/5G Gene Polymorphism and Nontraumatic Lunatum Avascular Necrosis.
Gönen M; Yörükoğlu AÇ; Aydemir AN; Gönen GA; Tepeli E; Demirkan AF
J Hand Surg Am; 2020 May; 45(5):450.e1-450.e4. PubMed ID: 31806394
[TBL] [Abstract][Full Text] [Related]
6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study.
Giurgea GA; Brunner-Ziegler S; Jilma B; Sunder-Plassmann R; Koppensteiner R; Gremmel T
Thromb Res; 2017 May; 153():71-75. PubMed ID: 28347810
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
10. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
[TBL] [Abstract][Full Text] [Related]
11. The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease.
Sans M; Tàssies D; Pellisé M; Espinosa G; Quintó L; Piqué JM; Reverter JC; Panés J
Aliment Pharmacol Ther; 2003 Apr; 17(8):1039-47. PubMed ID: 12694086
[TBL] [Abstract][Full Text] [Related]
12. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
[TBL] [Abstract][Full Text] [Related]
13. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
Malle EM; Posch-Pertl L; Renner W; Pinter-Hausberger S; Singer C; Haas A; Wedrich A; Weger M
Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
[TBL] [Abstract][Full Text] [Related]
14. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
[TBL] [Abstract][Full Text] [Related]
15. PAI-1 donor polymorphism influences long-term kidney graft survival.
Rérolle JP; Munteanu E; Drouet M; Szelag JC; Champtiaux B; Yagoubi F; Preux PM; Aldigier JC; Le Meur Y
Nephrol Dial Transplant; 2008 Oct; 23(10):3325-32. PubMed ID: 18463321
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
[TBL] [Abstract][Full Text] [Related]
17. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.
Nagi DK; McCormack LJ; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetes Care; 1997 Aug; 20(8):1304-9. PubMed ID: 9250459
[TBL] [Abstract][Full Text] [Related]
18. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 activity and 4G/5G polymorphism in hemodialysis.
Trimarchi H; Duboscq C; Genoud V; Lombi F; Muryan A; Young P; Schwab M; Castanon M; Rodriguez-Reimundes E; Forrester M; Pereyra H; Campolo-Girard V; Seminario O; Alonso M; Kordich L
J Vasc Access; 2008; 9(2):142-7. PubMed ID: 18609532
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]